Masimo (MASI) Projected to Post Quarterly Earnings on Tuesday

Masimo (NASDAQ:MASI) is expected to be issuing its quarterly earnings data after the market closes on Tuesday, February 25th. Analysts expect the company to announce earnings of $1.42 per share and revenue of $593.35 million for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.

Masimo Price Performance

Masimo stock opened at $181.31 on Tuesday. Masimo has a 12 month low of $101.61 and a 12 month high of $183.14. The stock’s 50 day moving average is $172.65 and its 200-day moving average is $150.39. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $9.71 billion, a price-to-earnings ratio of 125.04 and a beta of 1.02.

Analyst Upgrades and Downgrades

Several research firms have weighed in on MASI. Piper Sandler upped their target price on Masimo from $180.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 18th. Wells Fargo & Company increased their price objective on Masimo from $171.00 to $193.00 and gave the company an “overweight” rating in a report on Wednesday, December 11th. Needham & Company LLC reiterated a “hold” rating on shares of Masimo in a report on Wednesday, January 22nd. Stifel Nicolaus reiterated a “buy” rating and set a $190.00 price target (up from $170.00) on shares of Masimo in a report on Friday, November 22nd. Finally, Raymond James increased their price target on Masimo from $170.00 to $194.00 and gave the stock an “outperform” rating in a report on Friday, December 27th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $191.40.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.